Interestingly, in α6KO/Brca1p53-KO mutants, luminal progenitors displayed higher levels of Cdkn2a transcripts than Itgα6-proficient cells, while no difference was detected between both groups at the tumor stage (Fig. 5B). The gene discussed is CDKN2A; the disease is neoplasm.